Cleared Traditional

K962176 - TPP

K962176 is an FDA 510(k) clearance for TPP, manufactured by Panbio, Inc.. The device is a Class 2 Hematology device with product code MIF cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K962176 · Panbio, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1996
Decision
135d
Days
Class 2
Risk

K962176 is an FDA 510(k) clearance for the TPP. Classified as Prothrombin Fragment 1.2 (product code MIF), Class II - Special Controls.

Submitted by Panbio, Inc. (South Bend, US). The FDA issued a Cleared decision on October 18, 1996 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Panbio, Inc. devices

FDA 510(k) Submission Details - K962176

510(k) Number K962176 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 1996
Decision Date October 18, 1996
Days to Decision 135 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 113d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MIF Device Classification - Class 2, Special Controls

Product Code MIF Prothrombin Fragment 1.2
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - MIF Prothrombin Fragment 1.2

Devices cleared under the same product code (MIF) and FDA review panel - the closest regulatory comparables to K962176.
ENZYGNOST F+2 (MONOCLONAL) TEST KIT
K042687 · Dade Behring, Inc. · Dec 2004
THROMBONOSTIKA F1.2
K964934 · Organon Teknika Corp. · Mar 1997
ENZYGNOST F 1+2
K922934 · Behring Diagnostics, Inc. · Nov 1992
DADE(R) PROTHROMBIN FRAGMENT F1.2 ELISA
K920895 · Baxter Diagnostics, Inc. · Jun 1992
THROMBONOSTIKA F1.2
K911434 · Organon Teknika Corp. · Oct 1991